Edition:
United States

People: Cempra Inc (CEMP.O)

CEMP.O on Nasdaq

7.50USD
5 Dec 2016
Change (% chg)

-- (--)
Prev Close
$7.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,659,757
52-wk High
$32.31
52-wk Low
$5.70

Kong, Garheng 

Dr. Garheng Kong, M.D., Ph.D., is an Independent Chairman of the Board of Cempra, Inc. Dr. Kong has served on our Board since September 2006 and as Chairman of our Board since November 2008. Dr. Kong has been the Managing Partner of Sofinnova Healthquest, a healthcare investment firm, since July 2013. He was a general partner at Sofinnova Ventures, a venture firm focused on life sciences, from September 2010 to December 2013. From 2000 to September 2010, he was at Intersouth Partners, a venture capital firm, most recently as a general partner, where he was a founding investor or board member for various life sciences ventures, several of which were acquired by large pharmaceutical companies. Dr. Kong has also served on the board of directors of Histogencis Corporation (NASDAQ: HSGX), a regenerative medicine company, since July 2012, Alimera Sciences, Inc. (NASDAQ: ALIM), a biopharmaceutical company, since October 2012, and has served on the board of Laboratory Corporation of America Holdings (NYSE: LH), a healthcare company, since December 2013. Dr. Kong holds a B.S. from Stanford University. He holds an M.D., Ph.D. and M.B.A. from Duke University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Garheng Kong

--

Prabhavathi Fernandes

2,321,550

Mark Hahn

1,002,860

John Bluth

--

David Moore

1,385,230

David Oldach

--
As Of  30 Dec 2014